Home
Conditions
Primary Peritoneal Cancer

Clinical trial condition

Primary Peritoneal Cancer

Explore clinical trials studying Primary Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

91 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Primary Peritoneal Cancer trial results

Recruiting

HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer

NCT06014190

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +21 more
Locations: Anhui Provincial Cancer Hospital Hefei, Anfei, China

Lingying Wu Beijing, Beijing Municipality, China

Peking University Cancer Hospital Beijing, Beijing Municipality, China

Chongqing University cancer Hospital Chongqing, Chongqing Municipality, China

View all 28 locations

View Trial Details

Not Yet Recruiting

A Real-world Study of Mirvetuximab Soravtansine (MIRV) in Ovarian Cancer Patients of Expression of Folate Receptor α（FRα）

NCT07690332

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With HER2-Expressing Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT07545460

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Yunnan Cancer Hospital Kunming, Yunnan, China

View Trial Details

Not Yet Recruiting

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

NCT07591831

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

NCT07489300

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer

NCT07432594

Conditions: Adnexal Diseases, Fallopian Tube Cancers, Fallopian Tube Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT07044349

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

NCT06063070

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations: Sun Yat-sen University Cancer Cetntre Guangzhou, Guangdong, China

View Trial Details

Completed

Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer

NCT07648745

Conditions: Adnexal Diseases, Bowel Obstruction, Digestive System Diseases, +22 more
Locations: The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

NCT04539327

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Hospital Torrecárdenas Almería, Andalusia, Spain

Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain

Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain

Hospital Universitario Nuestra Señora de Valme Seville, Andalusia, Spain

View all 23 locations

View Trial Details

Primary Peritoneal Cancer

Primary Peritoneal Cancer trial results

Related conditions